BMJ Group: GLP-1 Agonists Linked to Significantly Lower Long Term Risk of Knee Replacement
June 04, 2026
June 04, 2026
LONDON, England, June 4 (TNSjou) -- BMJ Group issued the following news release about Regional Anesthesia & Pain Medicine:
* * *
GLP-1 agonists linked to significantly lower long term risk of knee replacement
Greatest effect seen with sustained use and newer agents semaglutide and tirzepatide
-
GLP-1 receptor agonist drugs, used for the treatment of diabetes, and more recently, weight loss, are associated with a significantly l . . .
* * *
GLP-1 agonists linked to significantly lower long term risk of knee replacement
Greatest effect seen with sustained use and newer agents semaglutide and tirzepatide
-
GLP-1 receptor agonist drugs, used for the treatment of diabetes, and more recently, weight loss, are associated with a significantly l . . .